# Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population

> **NCT03543774** · PHASE4 · UNKNOWN · sponsor: **Hue University of Medicine and Pharmacy** · enrollment: 30 (estimated)

## Conditions studied

- Hypercholesterolemia
- Chronic Kidney Diseases

## Interventions

- **DRUG:** Simvastatin 40mg
- **DRUG:** Ezetimibe/simvastatin 10/20 mg/day
- **DRUG:** Ezetimibe/simvastatin 10/40 mg/day

## Key facts

- **NCT ID:** NCT03543774
- **Lead sponsor:** Hue University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-15
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-10-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03543774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03543774, "Lipid-lowering Therapies in Vietnamese Chronic Kidney Disease Population". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03543774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*